Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RATATA: Adjuvant Tranexamic Acid for Chronic Subdural Hematoma
NCT07245264Phase 3Recruiting
- Sponsor
- St. Olavs University Hospital
- Start
- Dec 2025
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in chronic subdural hematoma (CSDH), sponsored by St. Olavs University Hospital. Started Dec 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT07245264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245264.